Abingdon Health Plc Stock Performance
| ABDXF Stock | USD 0.07 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Abingdon Health are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Abingdon Health Plc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Abingdon Health is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 5 M | |
| Total Cashflows From Investing Activities | -756 K |
Abingdon |
Abingdon Health Relative Risk vs. Return Landscape
If you would invest 7.00 in Abingdon Health Plc on November 8, 2025 and sell it today you would earn a total of 0.00 from holding Abingdon Health Plc or generate 0.0% return on investment over 90 days. Abingdon Health Plc is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Abingdon, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Abingdon Health Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Abingdon Health for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Abingdon Health Plc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Abingdon Health Plc generated a negative expected return over the last 90 days | |
| Abingdon Health Plc has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 2.83 M. Net Loss for the year was (21.26 M) with loss before overhead, payroll, taxes, and interest of (3.59 M). | |
| Abingdon Health Plc has accumulated about 5.96 M in cash with (7.74 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05. | |
| Roughly 54.0% of the company shares are held by company insiders |
Abingdon Health Fundamentals Growth
Abingdon Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Abingdon Health, and Abingdon Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Abingdon Pink Sheet performance.
| Return On Equity | -1.53 | |||
| Return On Asset | -0.32 | |||
| Operating Margin | (4.19) % | |||
| Current Valuation | 5.33 M | |||
| Shares Outstanding | 121.72 M | |||
| Price To Book | 0.33 X | |||
| Price To Sales | 3.31 X | |||
| Revenue | 2.83 M | |||
| EBITDA | (12.7 M) | |||
| Cash And Equivalents | 5.96 M | |||
| Cash Per Share | 0.05 X | |||
| Total Debt | 435 K | |||
| Debt To Equity | 0.06 % | |||
| Book Value Per Share | 0.02 X | |||
| Cash Flow From Operations | (7.74 M) | |||
| Total Asset | 12.77 M | |||
About Abingdon Health Performance
By analyzing Abingdon Health's fundamental ratios, stakeholders can gain valuable insights into Abingdon Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Abingdon Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Abingdon Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Abingdon Health Plc develops, manufactures, and distributes diagnostic devices worldwide. Abingdon Health Plc was incorporated in 2008 and is headquartered in York, the United Kingdom. Abingdon Health operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 123 people.Things to note about Abingdon Health Plc performance evaluation
Checking the ongoing alerts about Abingdon Health for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Abingdon Health Plc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Abingdon Health Plc generated a negative expected return over the last 90 days | |
| Abingdon Health Plc has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 2.83 M. Net Loss for the year was (21.26 M) with loss before overhead, payroll, taxes, and interest of (3.59 M). | |
| Abingdon Health Plc has accumulated about 5.96 M in cash with (7.74 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05. | |
| Roughly 54.0% of the company shares are held by company insiders |
- Analyzing Abingdon Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Abingdon Health's stock is overvalued or undervalued compared to its peers.
- Examining Abingdon Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Abingdon Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Abingdon Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Abingdon Health's pink sheet. These opinions can provide insight into Abingdon Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Abingdon Pink Sheet analysis
When running Abingdon Health's price analysis, check to measure Abingdon Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abingdon Health is operating at the current time. Most of Abingdon Health's value examination focuses on studying past and present price action to predict the probability of Abingdon Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abingdon Health's price. Additionally, you may evaluate how the addition of Abingdon Health to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |